Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Boehringer Ingelheim to develop and market Procysteine in Japan

Dec. 24, 1997

Jouveinal patents PDE IV inhibitors

Dec. 24, 1997

HNE inhibitors prepared at Glaxo Wellcome

Dec. 24, 1997

Neurokinin antagonists in the pipeline at Schering-Plough

Dec. 23, 1997

Schering-Plough obtains rights to Claritin metabolite from Sepracor

Dec. 22, 1997

Vyrex's respiratory antioxidant shows potential as asthma therapy

Dec. 22, 1997

Patient enrollment completed for ARDS phase Ib trial

Dec. 18, 1997

Singulair available in Mexico for asthma

Dec. 17, 1997

Atopy associated with IL-4R mutation; findings support Immunex's development of soluble IL-4R

Dec. 15, 1997

Yamanouchi describes development of dual NK1/NK2 antagonist

Dec. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...